Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7.8M

Overview

Alva Health is a neurotechnology company focused on revolutionizing stroke care through early detection. Founded by Yale experts, the company addresses the critical unmet need where 90% of stroke victims don't receive timely medical care, despite stroke affecting 700,000 Americans annually and costing the healthcare system over $53B. Their technology platform uses wearable devices to monitor for stroke indicators and automatically alert emergency services, potentially reducing disability and healthcare costs.

NeurologyStrokeEmergency Medicine

Technology Platform

Patented wearable devices with continuous monitoring algorithms that detect signatures indicative of stroke and automatically connect users with emergency responders.

Funding History

3
Total raised:$7.8M
Seed$4.5M
Seed$3M
Grant$257K

Opportunities

The aging US population and high stroke incidence (700,000 annually) create a large addressable market.
Successful technology could reduce the $53B annual stroke healthcare burden and establish a new standard of care for remote monitoring of high-risk patients.

Risk Factors

Regulatory approval for medical devices is challenging, and clinical validation must demonstrate both safety and efficacy.
Adoption barriers include convincing patients to wear devices continuously and integrating with existing emergency response systems.

Competitive Landscape

Competition includes traditional medical alert systems and consumer wearables with health features, but Alva Health differentiates with stroke-specific algorithms, automatic emergency response, and strong clinical validation from Yale neurology expertise.